Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

LuciDarax(Daraxonrasib) Daily Precautions

During treatment with LuciDarax(Daraxonrasib), please have blood counts and biochemistry tests reviewed as directed by your physician. If severe rash, an increase in bowel movement···【more】
Article source：Captain MedicineRelease date：2026-10-14Recommended：174
LuciDarax(Daraxonrasib) Daily Medication Precautions

Before using LuciDarax(Daraxonrasib), prophylactic skin care is required. Prepare topical glucocorticoids (to be applied to the face and chest as directed by the physician), a whol···【more】
Article source：Captain MedicineRelease date：2026-10-14Recommended：177
Dordaviprone(LuciDorda)

For treatment of H3 K27M-mutant diffuse midline glioma progressing after prior therapy in adults and children ≥1 year.【more】
Article source：Captain MedicineRelease date：2026-10-13Recommended：9
LuciDarax(Daraxonrasib) Dosage and Administration

The recommended dose of LuciDarax(Daraxonrasib) is 300 mg, orally, once daily, until disease progression or unacceptable toxicity. LuciDarax(Daraxonrasib) is available only as 100 ···【more】
Article source：Captain MedicineRelease date：2026-10-12Recommended：203
LuciDarax(Daraxonrasib) Medication Guide

LuciDarax(Daraxonrasib) is an oral pan-RAS inhibitor for adults with metastatic pancreatic adenocarcinoma whose disease has failed at least one prior line of systemic therapy or wh···【more】
Article source：Captain MedicineRelease date：2026-10-12Recommended：262
Uses and Effects of LuciDarax(Daraxonrasib)

During treatment with LuciDarax(Daraxonrasib), please follow your doctor's instructions for follow-up visits and imaging assessments. Do not increase the dose or stop the drug ···【more】
Article source：Captain MedicineRelease date：2026-10-10Recommended：259
What drug is LuciDarax(Daraxonrasib)?

LuciDarax(Daraxonrasib) was approved by the U.S. FDA on August 26, 2026, under the brand name RASONQUE. It is the first oral targeted drug approved in the United States that direct···【more】
Article source：Captain MedicineRelease date：2026-10-10Recommended：291
Daraxonrasib(LuciDarax)

Daraxonrasib for adults with metastatic pancreatic adenocarcinoma who have had ≥1 prior therapy or cannot receive combination anticancer therapy.【more】
Article source：Captain MedicineRelease date：2026-10-10Recommended：89
Precautions for Daily Use of Quizartinib

Quizartinib is a prescription drug; the dosage and course of treatment are determined by a hematologist. Do not adjust the dosage or stop the medication on your own. During the tre···【more】
Article source：Captain MedicineRelease date：2026-09-30Recommended：169
Cenobamate(LuciCeno)

Adjunctive therapy for focal-onset seizures (with or without secondary generalization) in adults inadequately controlled by ≥2 antiseizure medications.【more】
Article source：Captain MedicineRelease date：2026-09-30Recommended：22
Prescribing Information for Cobimetinib

Cobimetinib (Cotellic) is an oral, highly selective MEK1/2 inhibitor. Cobimetinib reversibly inhibits the catalytic activity of MEK1 and MEK2, blocking the phosphorylation and acti···【more】
Article source：Captain MedicineRelease date：2026-09-29Recommended：169
Role and Efficacy of Sunitinib

In the field of cancer therapy, the emergence of targeted medications has brought new hope to many patients with advanced cancer. Sunitinib (Sunitinib, Sutent) is precisely such an···【more】
Article source：Captain MedicineRelease date：2026-09-28Recommended：182

home page previous 4 4/107 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：8542025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：10512024-09-07
Lucius: Use only the official anti-counterfeiting website and beware of counterfeit LuciTir
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】

Recommended：3172026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：4082026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：6022026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：5802026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：4622026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：6132026-31-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More